PuriCore
Biotechnology ResearchPennsylvania, United States51-200 Employees
PuriCore is a biotechnology research company headquartered in Malvern, Pennsylvania. It operates in the biopharmaceutical sector, pursuing proprietary technologies to support health benefits for adults and children, including development efforts in small molecule immunomodulatory therapies for inflammatory diseases with potential applications in dermatology, ophthalmology, and rare conditions. The company serves markets in Health Sciences with a wound care solution designed to cleanse, debride, and moisturize both chronic and acute wounds such as diabetic ulcers and burns, and it also markets products for supermarket retail aimed at extending the freshness of produce and flowers through its Sterilox Fresh offering. PuriCore positions itself within the life sciences ecosystem as an emerging player focused on developing therapeutic candidates while supporting commercial applications in consumer retail and health care settings. The firm is listed on the London Stock Exchange and maintains operations in the United States, reflecting a transatlantic footprint tied to its Malvern base and its broader development activities.